Dr Lauren Bor obtained her Ph.D in Immunobiology, titled “ The Generation of MHC Class I Restricted Antigen Specific Regulatory T Cells for the treatment of Type 1 Diabetes” from Kings College London in 2014. Lauren then joined the lab of Professor Waseem Qasim at University College London as a Post Doctoral Researcher where she led the development of closed-system, automated manufacturing platforms for CAR T cells. Following successful manufacture of CD19 CAR T cells for clinical trials and scale up of gene edited CAR T cells at UCL, Lauren moved to TC BioPharm in 2019 where she is now Process Development Manager. At TC BioPharm, Lauren’s area of research has been the process development and technology transfer of TC BioPharms’ Unmodified cryopreserved Vγ9Vδ2 T cell manufacturing process